UNSPSC 41142053: Tacrolimus test system

In this classification, Tacrolimus test system connotes a device used to measure Tacrolimus levels. US FDA regulates Tacrolimus test system under 21 CFR 862.1678 and under FDA product code MLM.

UNSPSC 41142053 Tacrolimus test system is a Commodity code covering immunological and chemical test systems and reagent kits used in forensic drug analysis, toxicology screening, and disease-surveillance testing by state and local public health, law enforcement, and environmental agencies. Recent solicitations show state and local buyers procuring Direct ELISA testing kits for controlled-substance screening, mosquito-borne disease detection systems (West Nile Virus, Dengue), certified reference drug standards for forensic laboratory validation, and DNA screening kits for state laboratory operations. The issuing bodies include state departments of public safety, health and human services, law enforcement, and environmental agencies; county forensic laboratories; and special health and forensic authorities. Texas and Illinois dominate the recent activity, with Florida also active. The mix reflects specialized, mission-critical procurement by high-compliance forensic and public-health units rather than broad municipal purchasing.

The Texas Department of Public Safety posted IFB 405-26R0008445A on July 9, 2026, requesting Direct ELISA reagent kits for cannabinoid, opioid, and controlled-substance analysis with bids due July 23, 2026, under a sole-source or proprietary framework allowing equivalent-product competition. Pinellas County, Florida, and the Florida Department of Law Enforcement jointly issued Invitation to Quote 26-0305-ITQ on April 23, 2026, for 131 line items of certified reference drug standards meeting ISO/IEC 17025:2017 accreditation, funded through the Paul Coverdell Forensic Sciences Improvement Act Program with approximately $49,034.00 allocated for equipment and supplies. The Illinois Department of Financial and Professional Regulation's Centralized Maintenance Services established a joint-purchase master contract for RAMP mosquito-testing systems (West Nile Virus and Dengue test kits) through a sole-source award to ADAPCO, LLC, with notice posted May 4, 2026. The Texas Health and Human Services Commission sought QIAxcel and QIAamp DNA screening kits through competitive IFB HHS0016902v2 with a due date of January 29, 2026, and historical procurement value between $25,050.00 and $30,000.00 for fiscal year 2025. These solicitations emphasize strict accreditation standards, firm pricing with 12-month terms, and compliance with federal forensic and public-health regulatory frameworks.